Conceivable Life Sciences Secures $50 Million Series A
Summary
Conceivable Life Sciences raised $50 million in Series A funding to speed up development and commercialization of its AI-powered automated IVF laboratory. The company says its AURA platform uses robotics, AI, and advanced optics to standardize more than 200 IVF lab steps. It is already running a 100-patient pilot study and reports promising early clinical results. The new capital will support a U.S. market launch next year and expansion of fertility network partnerships in 2026. The company aims to improve consistency, scalability, and access in fertility care.
Funding
Amount
$50.0M
Total raised
Date
September 15, 2025
Announcement date
Investors
SMARTECH AV CO., Advance Venture Partners
Lead investors
Company
conceivable.life
Funded company
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
No AI classifications detected